Fighting Back Against Terror

After two pipe bombs damaged their buildings in 2003, and after employees had been repeatedly harassed at their homes by animal rights activists wielding bullhorns and sirens, Chiron Corp. decided enough was enough.

Written byTed Agres
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

After two pipe bombs damaged their buildings in 2003, and after employees had been repeatedly harassed at their homes by animal rights activists wielding bullhorns and sirens, Chiron Corp. decided enough was enough. The Emeryville, Calif., biopharmaceutical company last year filed a lawsuit against the activists. They won a preliminary injunction restricting their protests. "When all the activity against us began, we thought if we kept our head down, it would go away," says Chiron spokesman John Gallagher. "In fact, it did not." Since winning the injunction, he said, "it's been pretty quiet."

Even as Chiron and other companies in the United States and the United Kingdom have discovered the value in using the law to fight back against animal rights activists, extremists are adopting new and increasingly violent tactics in their drive to shut down biomedical laboratories, biotech, and pharmaceutical companies that use or rely on animals in research. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies